CK22-008 Midwest Virtual Laboratory of Pathogen Transmission in Healthcare Settings (MVL-PATHS)
Project Number5U01CK000671-02
Contact PI/Project LeaderBANI YAGHOUB, MAJID
Awardee OrganizationUNIVERSITY OF MISSOURI KANSAS CITY
Description
Abstract Text
Midwest Virtual Laboratory of Pathogen Transmission in Healthcare Settings (MVL-PATHS)
Project Summary
Antimicrobial Resistant (AMR) pathogens have become a significant public health threat. Also, the COVID-19
pandemic has further revealed disparities in healthcare settings. By developing and implementing novel
mathematical and computation models, the long-term goals are to optimize AMR control and preventive
interventions and to improve the health equity. The central hypothesis is that the outputs of mathematical and
computation models will provide optimized and effective guidelines to reduce the threat of AMR pathogen spread
and reduce health disparities in healthcare settings. The rationale underlying this project is to fill the critical gap in
modeling workforce capacity and develop a new generation of mathematical models for healthcare research. The
central hypothesis will be tested by pursuing three specific aims to develop and employ a, (i) One Health modeling
approach to understand the source, distribution and spread of AMR Enterobacteriaceae with a focus on Extended-
spectrum beta-lactamase (ESBL)-producing E. coli, (ii) a novel Real-Time modeling approach to identify AMR
pathogen transmission by asymptomatic spreaders and contaminated medical devices in hospitals, (iii) a novel
Agent-Based Nested modeling approach to identify the effects of caregivers as vectors of disease spread, and effects
of limited staffing and specialized care on equitable quality of care in nursing homes. We will pursue these aims
using an innovative combination of mathematical and computational modeling techniques. These include both
recently developed techniques of including human behavior in models and more-established techniques that have
been applied very little to the study of health equity and AMR pathogen spread. The workforce development
objectives of this proposal are to (i) enhance mathematical and computational modeling research capabilities of the
public health workforce and (ii) increase the number of junior modeling professionals that are trained and
experienced in modeling transmission of pathogens in healthcare settings partly incorporated with health disparities.
The expected outcomes of this work are the successful training of five predoctoral fellows and creating a virtual
laboratory of enhanced mathematical models to identify strategies for reducing the threat AMR pathogen spread
and reducing health disparities. The results will have an important positive impact immediately because the virtual
laboratory can also be used by healthcare professionals to further investigate the drivers of disease spread and
estimate the relative benefits of multiple control and prevention strategies in a timely and cost-effective manner. In
addition, the research outputs of this project will expand and strengthen national one-health efforts to combat
resistance and will have a direct impact on CDC and its public health partners’ ability to reduce the costs, morbidity
and mortality of healthcare associated infections.
Public Health Relevance Statement
Project narrative
This research will create and implement new tools for (i) identifying asymptomatic spreaders of
antimicrobial-resistant pathogens in hospital settings, and (ii) measuring the efficacy of behavioral
versus clinical interventions to reduce antimicrobial-resistant infections in hospitals, and to reduce
health disparities in nursing homes.
National Center for Emerging and Zoonotic Infectious Diseases
CFDA Code
084
DUNS Number
010989619
UEI
J9CDGR596MN3
Project Start Date
30-September-2022
Project End Date
29-September-2025
Budget Start Date
30-September-2023
Budget End Date
29-September-2024
Project Funding Information for 2023
Total Funding
$183,028
Direct Costs
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2023
National Center for Emerging and Zoonotic Infectious Diseases
$183,028
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U01CK000671-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U01CK000671-02
Patents
No Patents information available for 5U01CK000671-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U01CK000671-02
Clinical Studies
No Clinical Studies information available for 5U01CK000671-02
News and More
Related News Releases
No news release information available for 5U01CK000671-02
History
No Historical information available for 5U01CK000671-02
Similar Projects
No Similar Projects information available for 5U01CK000671-02